jardiance a glp 1 GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal jardiance glp 1 is jardiance

The five-year risk of end-stage kidney disease was 1.6% for the GLP-1-RA group vs

But apart from that, there are two main things we should pay attention to: vitamin C and glutathione

The body uses amino acids as building blocks to make proteins

Sure, you lose some weight, but 40% of it muscle so you end up "skinny fat" with a slower metabolism than you had when you first started

10 Conclusion and perspectives DKD, a serious DM-related microvascular disorder, is pathologically defined by persistent hyperglycemia-triggered complex metabolic abnormalities, ultimately leading to glomerular filtration barrier destruction and tubulointerstitial injury (13, 132, 224)

One analysis determined that participants who stopped taking GLP1-drugs had regained about two-thirds of their previous weight loss after one year